{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:42:51Z","timestamp":1792017771341,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.lungcan.2011.05.013","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T10:01:20Z","timestamp":1308996080000},"page":"492-496","source":"Crossref","is-referenced-by-count":35,"title":["Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: Evaluation of efficacy and toxicity"],"prefix":"10.1016","volume":"74","author":[{"given":"Yusuke","family":"Okuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuru","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2011.05.013_bib0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","article-title":"Thymic carcinoma: state of the art review","volume":"59","author":"Eng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000478-197706000-00002","article-title":"Squamous cell carcinoma of the thymus. An analysis of eight cases","volume":"1","author":"Shimosato","year":"1977","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0015","series-title":"Pathology and genetics of tumors of the lung, pleura, thymus and heart","article-title":"World Health Organization classification of tumors","author":"Travis","year":"2004"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","volume":"98","author":"Yoh","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0025","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1200\/JCO.1991.9.9.1632","article-title":"Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer","volume":"9","author":"Murray","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMoa003034","article-title":"Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer","volume":"346","author":"Noda","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0040","series-title":"WHO International Histological Classification of Tumours","article-title":"Histological typing of tumors of the thymus","author":"Rosai","year":"1999"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-642-82480-7_7","article-title":"Pathology of thymic epithelial tumors","volume":"75","author":"Muller-Hermelink","year":"1986","journal-title":"Curr Top Pathol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0050","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T","article-title":"Thymoma. Histologic subclassification is an independent prognostic factor","volume":"74","author":"Quintanilla-Martinez","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","article-title":"Thymic hyperplasia and neoplasia: a review of current concepts","volume":"9","author":"Levine","year":"1978","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0065","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0070","doi-asserted-by":"crossref","unstructured":"Petrini I, Zucali PA, Lee HS, Pineda MA, Meltzer PS, Walter-Rodriguez B, et al. Expression and mutational status of c-kit in thymic epithelial tumors. J Thorac Oncol;5:1447\u201353.","DOI":"10.1097\/JTO.0b013e3181e96e30"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","article-title":"Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)","volume":"25","author":"Koizumi","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0080","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lungcan.2007.05.016","article-title":"Multimodal treatment of thymic carcinoma: report of nine cases","volume":"59","author":"Magois","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.lungcan.2007.07.003","article-title":"Response of a thymic mucoepidermoid carcinoma to combination chemotherapy with cisplatin and irinotecan: a case report","volume":"59","author":"Fuse","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0095","doi-asserted-by":"crossref","unstructured":"Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol, 2011;29:2060-5","DOI":"10.1200\/JCO.2010.32.9607"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2009.03.031","article-title":"Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma","volume":"67","author":"Igawa","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0105","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Strobel","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/030089160809400613","article-title":"Erlotinib in advanced well-differentiated thymic carcinoma with overexpression of EGFR: a case report","volume":"94","author":"Pedersini","year":"2008","journal-title":"Tumori"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0125","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000082626","article-title":"Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma","volume":"50","author":"Oguri","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0135","first-page":"1331","article-title":"Thymic carcinoma with autoimmune syndrome: successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin","volume":"17","author":"Hsu","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0140","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JTO.0b013e3181a52e74","article-title":"Thymic small cell carcinoma shows marked response to amrubicin","volume":"4","author":"Igawa","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.lungcan.2010.09.004","article-title":"S-1 is an active anticancer agent for advanced thymic carcinoma","volume":"70","author":"Okuma","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/annonc\/mdl377","article-title":"Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan","volume":"18","author":"Ohe","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.coc.0000164004.67196.59","article-title":"Malignant thymoma associated with fatal myocarditis and polymyositis in a 32-year-old woman with a history of hairy cell leukemia","volume":"29","author":"Gidron","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.05.013_bib0160","first-page":"4851","article-title":"Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma \u2013 three cases","volume":"26","author":"Komatsu","year":"2006","journal-title":"Anticancer Res"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500211002819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500211002819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T08:30:53Z","timestamp":1560328253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500211002819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0169500211002819"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2011.05.013","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}